PCP
UTHR icon

Proficio Capital Partners’s United Therapeutics UTHR Stock Holding History

Proficio Capital Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
+808
New +$455K 0.02% 372
2019
Q3 		– Sell
-39
Closed -$3K – 1466
2019
Q2 		$3K Sell
39
-11
-22% -$1.03K ﹤0.01% 1447
2019
Q1 		$6K Sell
50
-4
-7% -$466 ﹤0.01% 1072
2018
Q4 		$6K Sell
54
-63
-54% -$7.3K ﹤0.01% 843
2018
Q3 		$15K Buy
117
+16
+16% +$1.98K ﹤0.01% 697
2018
Q2 		$11K Sell
101
-41
-29% -$4.51K ﹤0.01% 807
2018
Q1 		$16K Sell
142
-9
-6% -$1.14K ﹤0.01% 663
2017
Q4 		$22K Buy
151
+23
+18% +$2.92K 0.01% 562
2017
Q3 		$15K Sell
128
-34
-21% -$4.34K 0.01% 673
2017
Q2 		$21K Sell
162
-12
-7% -$1.5K 0.01% 602
2017
Q1 		$21K Buy
174
+64
+58% +$9.7K 0.01% 606
2016
Q4 		$16K Buy
110
+87
+378% +$11.1K 0.01% 512
2016
Q3 		$3K Hold
23
– – ﹤0.01% 828
2016
Q2 		$3K Buy
23
+3
+15% +$335 ﹤0.01% 793
2016
Q1 		$2K Buy
20
+6
+43% +$759 ﹤0.01% 793
2015
Q4 		$2K Buy
+14
New +$2.04K ﹤0.01% 695

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Proficio Capital Partners's UTHR Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in United Therapeutics (UTHR) in Q2 2026: 808 shares worth $438K. The stake represents 0.02% of the portfolio and ranks #372 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in UTHR as recently as Q2 2019.

Proficio Capital Partners first reported a position in UTHR in Q4 2015 and has held it in 16 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Proficio Capital Partners held 808 shares of United Therapeutics worth $438K as of Q2 2026.
  • United Therapeutics was a new Proficio Capital Partners position in Q2 2026.
  • United Therapeutics made up 0.02% of Proficio Capital Partners's portfolio in Q2 2026, its #372 holding.
  • Proficio Capital Partners first reported a position in United Therapeutics in Q4 2015 and has held it in 16 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.